1. Comparison of nine prognostic scores in patients with brain metastases of breast cancer receiving radiotherapy of the brain
- Author
-
Cordula Petersen, E Laakmann, V Müller, Jan F. Kersten, Yvonne Goy, Kerstin Riecke, I Witzel, and Andreas Krüll
- Subjects
Adult ,0301 basic medicine ,Oncology ,Cancer Research ,medicine.medical_specialty ,Multivariate analysis ,medicine.medical_treatment ,Breast Neoplasms ,Recursive partitioning ,macromolecular substances ,03 medical and health sciences ,0302 clinical medicine ,Breast cancer ,stomatognathic system ,Germany ,Internal medicine ,Humans ,Medicine ,Karnofsky Performance Status ,Survival rate ,Aged ,Neoplasm Staging ,Aged, 80 and over ,Univariate analysis ,Hematology ,Brain Neoplasms ,business.industry ,General Medicine ,Middle Aged ,Prognosis ,medicine.disease ,Survival Rate ,Radiation therapy ,030104 developmental biology ,030220 oncology & carcinogenesis ,Multivariate Analysis ,Cohort ,Female ,Cranial Irradiation ,business ,Follow-Up Studies - Abstract
Several prognostic indices (PI) have been developed to stratify patients with brain metastases in groups with good or bad prognosis. The aim of our study was to compare nine prognostic scores for patients with brain metastases (BM) of breast cancer receiving radiotherapy. The clinical data of 139 breast cancer patients with BM were collected retrospectively. All patients were treated with cerebral radiotherapy or surgery followed by radiotherapy between January 2007 and December 2012. The prognostic value and accuracy of recursive partitioning analysis (RPA), RPA II, graded prognostic assessment (GPA), basic score for BM, Breast-RPA, Breast-GPA, Rades Score 2011, Germany Score and Breast Rades Score were assessed. The median survival after BM diagnosis in our cohort was 14 months. The overall 6-month, 1-, 2- and 3-year survival rates were 49.6, 37.4, 20.9 and 13.7 %, respectively. Most of the PI were associated with OS, but univariate analysis favored GPA regarding OS. GPA was the most accurate score to identify patients with long (longer than 12 months) and Breast-GPA patients with short (
- Published
- 2015
- Full Text
- View/download PDF